Kevin Raymond Merrill Smith - 10 Nov 2023 Form 4 Insider Report for Inogen Inc (INGN)

Role
CEO and President, Director
Signature
/s/ Leslyn Cicekli, as Attorney-in-Fact
Issuer symbol
INGN
Transactions as of
10 Nov 2023
Net transactions value
$0
Form type
4
Filing time
13 Nov 2023, 17:30:26 UTC
Previous filing
29 Jun 2021
Next filing
05 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INGN Restricted Stock Unit Award $0 -85,000 -50% $0.000000 85,000 10 Nov 2023 Common Stock 85,000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.
F2 Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest one year from December 1, 2023 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.